The store will not work correctly when cookies are disabled.
5-Bromo-N-(4-bromophenyl)-4-(2-fluoro-4-nitrophenoxy)pyrimidin-2-amine
ID: ALA4779407
PubChem CID: 162663675
Max Phase: Preclinical
Molecular Formula: C16H9Br2FN4O3
Molecular Weight: 484.08
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: O=[N+]([O-])c1ccc(Oc2nc(Nc3ccc(Br)cc3)ncc2Br)c(F)c1
Standard InChI: InChI=1S/C16H9Br2FN4O3/c17-9-1-3-10(4-2-9)21-16-20-8-12(18)15(22-16)26-14-6-5-11(23(24)25)7-13(14)19/h1-8H,(H,20,21,22)
Standard InChI Key: QARCGHJYBXBEBZ-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
11.2998 -8.6570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2986 -9.4838 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0130 -9.8965 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0112 -8.2445 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7261 -8.6534 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7249 -9.4860 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4413 -9.9009 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.4438 -8.2358 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
14.1647 -8.6554 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1635 -9.4838 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8792 -9.8973 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.5965 -9.4835 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5938 -8.6520 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.8775 -8.2423 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3111 -9.8948 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.0246 -9.4816 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7377 -9.8974 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4506 -9.4849 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4499 -8.6596 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7304 -8.2484 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0203 -8.6634 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0127 -10.7210 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
10.5850 -8.2452 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.8711 -8.6576 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.5848 -7.4207 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.1628 -8.2453 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 10 1 0
9 8 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 9 1 0
12 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
3 22 1 0
23 24 2 0
23 25 1 0
1 23 1 0
19 26 1 0
M CHG 2 23 1 25 -1
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 484.08 | Molecular Weight (Monoisotopic): 481.9025 | AlogP: 5.58 | #Rotatable Bonds: 5 |
Polar Surface Area: 90.18 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 7 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 12.74 | CX Basic pKa: 1.47 | CX LogP: 5.88 | CX LogD: 5.88 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.38 | Np Likeness Score: -1.78 |
References
1. Sun D,Yang Z,Zhen Y,Yang Y,Chen Y,Yuan Y,Zhang L,Zeng X,Chen L. (2020) Discovery of 5-bromo-4-phenoxy-N-phenylpyrimidin-2-amine derivatives as novel ULK1 inhibitors that block autophagy and induce apoptosis in non-small cell lung cancer., 208 [PMID:32961380] [10.1016/j.ejmech.2020.112782] |